Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.
Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
| - Industry | - Sector | Padraig McDonnell CEO | XMUN Exchange | US00846U1016 ISIN |
| US Country | 17,900 Employees | 6 Jan 2026 Last Dividend | 3 Nov 2014 Last Split | - IPO Date |
Agilent Technologies, Inc. stands as a global provider offering application-focused solutions primarily to the life sciences, diagnostics, and applied chemical sectors. The company propagates its mission across three distinct segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab, ensuring a broad spectrum of scientific research, diagnostic, and analytical needs are met worldwide. Since its establishment in 1999, Agilent has cemented its headquarters in Santa Clara, California, from where it orchestrates its global operations, offering an expansive portfolio through direct sales, distributors, resellers, and electronic commerce frameworks.